According to Inogen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.355942. At the end of 2023 the company had a P/S ratio of 0.7646.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.7646 | -36.16% |
2022 | 1.20 | -44.51% |
2021 | 2.16 | -32.67% |
2020 | 3.21 | -22.93% |
2019 | 4.16 | -44.92% |
2018 | 7.55 | -24.21% |
2017 | 9.96 | 48.49% |
2016 | 6.71 | 34.52% |
2015 | 4.99 | -6.12% |
2014 | 5.31 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() ResMed RMD | 5.23 | 1,368.13% | ๐บ๐ธ USA |
![]() Masimo MASI | 2.14 | 499.84% | ๐บ๐ธ USA |
![]() Chart Industries GTLS | 3.15 | 784.35% | ๐บ๐ธ USA |
![]() Allied Healthcare Products AHPI | 0.0006 | -99.83% | ๐บ๐ธ USA |
![]() Philips PHG | 0.9493 | 166.71% | ๐ณ๐ฑ Netherlands |